A tool to measure the economic impact of Hepatitis B elimination: A case study in Saudi Arabia

Background: No virologic cure exists for hepatitis B virus (HBV) infection, and existing therapies are designed to control viral replication. We aimed to estimate the national prevalence of HBsAg in 2017 and study the impact of an enhanced diagnosis rate and universal treatment administration on HBV...

Full description

Bibliographic Details
Main Authors: Faisal M. Sanai, Mohammed Alghamdi, Ellen Dugan, Abduljaleel Alalwan, Waleed Al-Hamoudi, Faisal Abaalkhail, Nasser AlMasri, Devin Razavi-Shearer, Homie Razavi, Jonathan Schmelzer, Faleh Z. Alfaleh
Format: Article
Language:English
Published: Elsevier 2020-11-01
Series:Journal of Infection and Public Health
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1876034120306407